Cargando…
Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria
Transdermal drug delivery avoids complications related to oral or parenteral delivery - the need for sterility, contamination, gastrointestinal side effects, patient unconsciousness or nausea and compliance. For malaria treatment, we demonstrate successful novel transdermal delivery of artemisone (A...
Autores principales: | Zech, Johanna, Dzikowski, Ron, Simantov, Karina, Golenser, Jacob, Mäder, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203570/ https://www.ncbi.nlm.nih.gov/pubmed/34116478 http://dx.doi.org/10.1016/j.ijpddr.2021.05.008 |
Ejemplares similares
-
Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
por: Zech, Johanna, et al.
Publicado: (2021) -
Emerging biology of noncoding RNAs in malaria parasites
por: Simantov, Karina, et al.
Publicado: (2022) -
Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria
por: Zelter, Tamir, et al.
Publicado: (2022) -
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
por: Golenser, Jacob, et al.
Publicado: (2020) -
Controlled release of artemisone for the treatment of experimental cerebral malaria
por: Golenser, Jacob, et al.
Publicado: (2017)